Bioplastics admitted to hospital

Two firms have created a waste recovery solution in hospitals - using bioplastics.  

Cellulac, an industrial biochemicals company, and Pharmafilter, a complex waste group, will make use of Cellulac’s environmentally-benign, low cost production bioplastic process which uses 2nd generation dairy and agriculture feedstocks.

Through this commercial partnership, Cellulac will produce up to 90% of the core ingredients for disposable single use items and personal hygiene products compatible with the Pharmafilter recovery system in hospitals.   

Gerard Brandon, CEO of Cellulac, said: “The Pharmafilter alliance with Cellulac is a classic definition of the bio-economy.  Producing, at volume, our low-cost, thermostable and high strength bioplastics for a technology partner would be a significant development alone.  However, it becomes transformative when combined with Pharmafilter’s hospital recovery system which is capable of recapturing energy and cleaning wastewater in a safe and environmentally friendly way.  Our partnership creates a low cost, vertically integrated supply chain solution that has a low carbon footprint and is environmentally friendly, positioning both cellulac and Pharmafilter as lynchpins in a circular bio-based economy.”  

Eduardo Van Den Berg Founder and CEO of Pharmafilter BV said: “Our innovative solution solves waste, wastewater and safety problem for hospitals by removing complex waste, sewage and wastewater streams emanating from hospitals.  Central to this solution is the requirement to secure a sustainable low cost and low carbon, high energy, end-of-life solution for single use bioplastics. cellulac’s innovative production and operational cost base opens the door for Pharmafilter to meet those targets and we look forward to rolling out the products over the next few years.”